Brian Park, PharmD, Author at MPR
Brian Park, PharmD

Brian Park, PharmD

Drug Information Specialist https://www.empr.com
Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

OPDIVO

Opdivo Plus Chemotherapy Approved for First-Line Treatment of Gastric Cancer

The Food and Drug Administration (FDA) has approved Opdivo® (nivolumab; Bristol Myers Squibb), in combination with fluoropyrimidine- and platinum-containing chemotherapy, for the first-line treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma. The approval was based on data from the multicenter, randomized, open-label phase 3 CheckMate-649 trial (ClinicalTrials.gov: NCT02872116),…